{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T07:11:40Z","timestamp":1777705900967,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T00:00:00Z","timestamp":1311638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T00:00:00Z","timestamp":1311638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1038\/pcan.2011.32","type":"journal-article","created":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T11:24:42Z","timestamp":1311679482000},"page":"354-360","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Quadriplex model enhances urine-based detection of prostate cancer"],"prefix":"10.1038","volume":"14","author":[{"given":"T","family":"Jamaspishvili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Kral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Khomeriki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Vyhnankova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Mgebrishvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Student","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"Kolar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Bouchal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,26]]},"reference":[{"key":"BFpcan201132_CR1","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.eururo.2005.06.009","volume":"48","author":"MP van Gils","year":"2005","unstructured":"van Gils MP, Stenman UH, Schalken JA, Schroder FH, Luider TM, Lilja H et al. Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project. Eur Urol 2005; 48: 1031\u20131041.","journal-title":"Eur Urol"},{"key":"BFpcan201132_CR2","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/ijc.20760","volume":"114","author":"KA Landers","year":"2005","unstructured":"Landers KA, Burger MJ, Tebay MA, Purdie DM, Scells B, Samaratunga H et al. Use of multiple biomarkers for a molecular diagnosis of prostate cancer. Int J Cancer 2005; 114: 950\u2013956.","journal-title":"Int J Cancer"},{"key":"BFpcan201132_CR3","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/pros.20490","volume":"66","author":"U Schmidt","year":"2006","unstructured":"Schmidt U, Fuessel S, Koch R, Baretton GB, Lohse A, Tomasetti S et al. Quantitative multi-gene expression profiling of primary prostate cancer. Prostate 2006; 66: 1521\u20131534.","journal-title":"Prostate"},{"key":"BFpcan201132_CR4","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1593\/neo.06625","volume":"8","author":"B Laxman","year":"2006","unstructured":"Laxman B, Tomlins SA, Mehra R, Morris DS, Wang L, Helgeson BE et al. Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer. Neoplasia 2006; 8: 885\u2013888.","journal-title":"Neoplasia"},{"key":"BFpcan201132_CR5","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1158\/0008-5472.CAN-07-3224","volume":"68","author":"B Laxman","year":"2008","unstructured":"Laxman B, Morris DS, Yu J, Siddiqui J, Cao J, Mehra R et al. A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Cancer Res 2008; 68: 645\u2013649.","journal-title":"Cancer Res"},{"key":"BFpcan201132_CR6","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1007\/s00120-008-1837-8","volume":"47","author":"S Schneider","year":"2008","unstructured":"Schneider S, Voigt S, Fussel S, Lohse-Fischer A, Tomasetti S, Haase M et al. [Molecular genetic markers for prostate cancer. Evidence in fine needle biopsies for improved confirmation of the diagnosis]. Urologe A 2008; 47: 1208\u20131211.","journal-title":"Urologe A"},{"key":"BFpcan201132_CR7","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1016\/j.juro.2009.01.110","volume":"181","author":"B Ouyang","year":"2009","unstructured":"Ouyang B, Bracken B, Burke B, Chung E, Liang J, Ho SM . A duplex quantitative polymerase chain reaction assay based on quantification of alpha-methylacyl-CoA racemase transcripts and prostate cancer antigen 3 in urine sediments improved diagnostic accuracy for prostate cancer. J Urol 2009; 181: 2508\u20132513; discussion 2513\u20132514.","journal-title":"J Urol"},{"key":"BFpcan201132_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2199-9-3","volume":"9","author":"M Noutsias","year":"2008","unstructured":"Noutsias M, Rohde M, Block A, Klippert K, Lettau O, Blunert K et al. Preamplification techniques for real-time RT-PCR analyses of endomyocardial biopsies. BMC Mol Biol 2008; 9: 3.","journal-title":"BMC Mol Biol"},{"key":"BFpcan201132_CR9","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW . A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.","journal-title":"Nucleic Acids Res"},{"key":"BFpcan201132_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2296-3-19","volume":"3","author":"RM Hoffman","year":"2002","unstructured":"Hoffman RM, Gilliland FD, Adams-Cameron M, Hunt WC, Key CR . Prostate-specific antigen testing accuracy in community practice. BMC Fam Pract 2002; 3: 19.","journal-title":"BMC Fam Pract"},{"key":"BFpcan201132_CR11","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1158\/1078-0432.CCR-06-2679","volume":"13","author":"MP van Gils","year":"2007","unstructured":"van Gils MP, Hessels D, van Hooij O, Jannink SA, Peelen WP, Hanssen SL et al. The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance. Clin Cancer Res 2007; 13: 939\u2013943.","journal-title":"Clin Cancer Res"},{"key":"BFpcan201132_CR12","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.urology.2006.12.014","volume":"69","author":"LS Marks","year":"2007","unstructured":"Marks LS, Fradet Y, Deras IL, Blase A, Mathis J, Aubin SM et al. PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy. Urology 2007; 69: 532\u2013535.","journal-title":"Urology"},{"key":"BFpcan201132_CR13","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.eururo.2008.06.071","volume":"54","author":"A Haese","year":"2008","unstructured":"Haese A, de la Taille A, van Poppel H, Marberger M, Stenzl A, Mulders PF et al. Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy. Eur Urol 2008; 54: 1081\u20131088.","journal-title":"Eur Urol"},{"key":"BFpcan201132_CR14","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1503\/cmaj.060955","volume":"176","author":"IM Thompson","year":"2007","unstructured":"Thompson IM, Ankerst DP . Prostate-specific antigen in the early detection of prostate cancer. CMAJ 2007; 176: 1853\u20131858.","journal-title":"CMAJ"},{"key":"BFpcan201132_CR15","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1097\/01.ju.0000137659.53129.14","volume":"172","author":"CG Rogers","year":"2004","unstructured":"Rogers CG, Yan G, Zha S, Gonzalgo ML, Isaacs WB, Luo J et al. Prostate cancer detection on urinalysis for alpha methylacyl coenzyme a racemase protein. J Urol 2004; 172: 1501\u20131503.","journal-title":"J Urol"},{"key":"BFpcan201132_CR16","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00345-010-0583-x","volume":"28","author":"C Prior","year":"2010","unstructured":"Prior C, Guillen-Grima F, Robles JE, Rosell D, Fernandez-Montero JM, Agirre X et al. Use of a combination of biomarkers in serum and urine to improve detection of prostate cancer. World J Urol 2010; 28: 681\u2013686.","journal-title":"World J Urol"},{"key":"BFpcan201132_CR17","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.ccr.2008.04.016","volume":"13","author":"SA Tomlins","year":"2008","unstructured":"Tomlins SA, Rhodes DR, Yu J, Varambally S, Mehra R, Perner S et al. The role of SPINK1 in ETS rearrangement-negative prostate cancers. Cancer Cell 2008; 13: 519\u2013528.","journal-title":"Cancer Cell"},{"key":"BFpcan201132_CR18","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1593\/neo.08922","volume":"10","author":"S Varambally","year":"2008","unstructured":"Varambally S, Laxman B, Mehra R, Cao Q, Dhanasekaran SM, Tomlins SA et al. Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer. Neoplasia 2008; 10: 1285\u20131294.","journal-title":"Neoplasia"},{"key":"BFpcan201132_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1677\/erc.1.01093","volume":"13","author":"L Zhang","year":"2006","unstructured":"Zhang L, Barritt GJ . TRPM8 in prostate cancer cells: a potential diagnostic and prognostic marker with a secretory function? Endocr Relat Cancer 2006; 13: 27\u201338.","journal-title":"Endocr Relat Cancer"},{"key":"BFpcan201132_CR20","first-page":"443","volume":"36","author":"VU Bai","year":"2010","unstructured":"Bai VU, Murthy S, Chinnakannu K, Muhletaler F, Tejwani S, Barrack ER et al. Androgen regulated TRPM8 expression: a potential mRNA marker for metastatic prostate cancer detection in body fluids. Int J Oncol 2010; 36: 443\u2013450.","journal-title":"Int J Oncol"},{"key":"BFpcan201132_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0304-3835(88)90205-4","volume":"43","author":"TR Teni","year":"1988","unstructured":"Teni TR, Sheth AR, Kamath MR, Sheth NA . Serum and urinary prostatic inhibin-like peptide in benign prostatic hyperplasia and carcinoma of prostate. Cancer Lett 1988; 43: 9\u201314.","journal-title":"Cancer Lett"},{"key":"BFpcan201132_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/(SICI)1097-0045(19980501)35:2<109::AID-PROS4>3.0.CO;2-E","volume":"35","author":"T Tsurusaki","year":"1998","unstructured":"Tsurusaki T, Koji T, Sakai H, Kanetake H, Nakane PK, Saito Y . Cellular expression of beta-microseminoprotein (beta-MSP) mRNA and its protein in untreated prostate cancer. Prostate 1998; 35: 109\u2013116.","journal-title":"Prostate"},{"key":"BFpcan201132_CR23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/pros.21059","volume":"70","author":"HC Whitaker","year":"2010","unstructured":"Whitaker HC, Warren AY, Eeles R, Kote-Jarai Z, Neal DE . The potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic target. Prostate 2010; 70: 333\u2013340.","journal-title":"Prostate"},{"key":"BFpcan201132_CR24","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S0002-9440(10)64244-7","volume":"161","author":"R Kuefer","year":"2002","unstructured":"Kuefer R, Varambally S, Zhou M, Lucas PC, Loeffler M, Wolter H et al. alpha-Methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiation. Am J Pathol 2002; 161: 841\u2013848.","journal-title":"Am J Pathol"},{"key":"BFpcan201132_CR25","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1158\/1055-9965.EPI-04-0801","volume":"14","author":"MA Rubin","year":"2005","unstructured":"Rubin MA, Bismar TA, Andren O, Mucci L, Kim R, Shen R et al. Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death. Cancer Epidemiol Biomarkers Prev 2005; 14: 1424\u20131432.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFpcan201132_CR26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.eururo.2010.11.026","volume":"59","author":"PN Nguyen","year":"2011","unstructured":"Nguyen PN, Violette P, Chan S, Tanguay S, Kassouf W, Aprikian A et al. A panel of TMPRSS2:ERG fusion transcript markers for urine-based prostate cancer detection with high specificity and sensitivity. Eur Urol 2011; 59: 407\u2013414.","journal-title":"Eur Urol"},{"key":"BFpcan201132_CR27","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/gcc.20327","volume":"45","author":"OR Saramaki","year":"2006","unstructured":"Saramaki OR, Tammela TL, Martikainen PM, Vessella RL, Visakorpi T . The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer. Genes Chromosomes Cancer 2006; 45: 639\u2013645.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFpcan201132_CR28","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nature01075","volume":"419","author":"S Varambally","year":"2002","unstructured":"Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002; 419: 624\u2013629.","journal-title":"Nature"},{"key":"BFpcan201132_CR29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0002-9440(10)63985-5","volume":"158","author":"K Specht","year":"2001","unstructured":"Specht K, Richter T, Muller U, Walch A, Werner M, Hofler H . Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. Am J Pathol 2001; 158: 419\u2013429.","journal-title":"Am J Pathol"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/pcan201132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/pcan201132","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/pcan201132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T21:23:01Z","timestamp":1648675381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pcan201132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,26]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["BFpcan201132"],"URL":"https:\/\/doi.org\/10.1038\/pcan.2011.32","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,26]]},"assertion":[{"value":"29 March 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}